CLDN-1 might enhance Zeb-1 levels through phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) pathway and Wnt/β-catenin pathway to suppress E-cadherin-related EMT pathogenesis in colon cancer [69]. This evidence concerns the gene ZEB1 and malignant colon neoplasm.